Compass Therapeutics Inc logo

Compass Therapeutics Inc

NAS:CMPX (USA)  
$ 1.96 +0.09 (+4.81%) 11:09 PM EST
P/E:
At Loss
P/B:
1.48
Market Cap:
$ 249.82M
Enterprise V:
$ 83.41M
Volume:
340.78K
Avg Vol (2M):
228.67K
Volume:
340.78K
Market Cap $:
249.82M
PE Ratio:
At Loss
Avg Vol (2M):
228.67K
Enterprise Value $:
83.41M
PB Ratio:
1.48

Business Description

Description
Compass Therapeutics Inc is a clinical-stage biopharmaceutical company that develops proprietary antibody therapeutics intended to engage the immune system to treat both solid tumors and hematological malignancies. It is engaged in drug discovery by leveraging its proprietary antibody discovery engine to broadly drug the immune system and identify optimal combinations empirically. Through StitchMabs and common light chain platforms, these combinatorial insights can be rapidly translated into tailored bispecifics with monoclonal-like manufacturability. The company has drugged over 40 immune targets and generated a diverse pipeline of monoclonal and multispecific therapeutic candidates with potential to transform care for patients with cancer or autoimmune diseases.
Name Current Vs Industry Vs History
Cash-To-Debt 71.99
Equity-to-Asset 0.94
Debt-to-Equity 0.01
Debt-to-EBITDA -0.05
Interest Coverage N/A
N/A
N/A
Piotroski F-Score 3/9
0
1
2
3
4
5
6
7
8
9
WACC vs ROIC
WACC
ROIC

Growth Rank

Name Current Vs Industry Vs History
3-Year EBITDA Growth Rate 16.1
3-Year EPS without NRI Growth Rate 17.8
3-Year FCF Growth Rate 19.2

Momentum Rank

Name Current Vs Industry Vs History
5-Day RSI 32.73
9-Day RSI 28.6
14-Day RSI 30.12
6-1 Month Momentum % -21.97
12-1 Month Momentum % 6.52

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 18.07
Quick Ratio 18.07
Cash Ratio 17.4

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -34.3
Shareholder Yield % 0.51

Financials (Next Earnings Date:2023-11-09 Est.)

CMPX's 30-Y Financials
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:CMPX

No Available Data

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014

Compass Therapeutics Inc Executives

Details

GF Value

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $)
EPS (TTM) ($) -0.37
Beta 0
Volatility % 69.59
14-Day RSI 30.12
14-Day ATR ($) 0.115829
20-Day SMA ($) 2.221
12-1 Month Momentum % 6.52
52-Week Range ($) 1.81 - 5.65
Shares Outstanding (Mil) 127.46

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 3
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Compass Therapeutics Inc Filings

Filing Date Document Date Form
No Filing Data

Compass Therapeutics Inc Stock Events

Event Date Price($)
No Event Data

Compass Therapeutics Inc Frequently Asked Questions

What is Compass Therapeutics Inc(CMPX)'s stock price today?
The current price of CMPX is $1.96. The 52 week high of CMPX is $5.65 and 52 week low is $1.81.
When is next earnings date of Compass Therapeutics Inc(CMPX)?
The next earnings date of Compass Therapeutics Inc(CMPX) is 2023-11-09 Est..
Does Compass Therapeutics Inc(CMPX) pay dividends? If so, how much?
Compass Therapeutics Inc(CMPX) does not pay dividend.

Press Release

Subject Date
No Press Release

Headlines

See More
  • 1
No news.
  • 1